14 Hospital Physician Board Review Manual www.turner-white.com
85. Nixon PA, Orenstein DM, Kelsey SF. Habitual physical activity in children and adolescents with cystic fibrosis. Med
Sci Sports Exerc 2001;33:30– 5.
86. Selvadurai HC, Blimkie CJ, Cooper PJ, et al. Gender differences in habitual activity in children with cystic fibrosis.
Arch Dis Child 2004;89:928–33.
87. Gruber W, Orenstein DM, Braumann KM, et al. Effects of
an exercise program in children with cystic fibrosis: are
there differences between females and males? J Pediatr
88. Prasad SA, Cerny FJ. Factors that influence adherence to
exercise and their effectiveness: application to cystic fibrosis. Pediatr Pulmonol 2002;34:66–72.
89. Craig S, Goldberg J, Dietz WH. Psychosocial correlates of
physical activity among fifth and eighth graders. Prev Med,
1996. 25( 5): p. 506-13.
90. Trost SG, Pate RR, Saunders R, et al. A prospective study
of the determinants of physical activity in rural fifth-grade
children. Prev Med 1997;26:257–63.
91. Dwyer TJ, Elkins MR, Bye PT. The role of exercise in
maintaining health in cystic fibrosis. Curr Opin Pulm Med
92. Rand S, Prasad SA. Exercise as part of a cystic fibrosis
therapeutic routine. Expert Rev Respir Med 2012;6:341–
93. Bradley J, Moran F. Physical training for cystic fibrosis.
Cochrane Database Syst Rev 2008( 1):CD002768.
94. Dwyer T, Zainuldin M. Effects of exercise and PEP on mu-cociliary clearance in adults with cystic fibrosis. 9th Australian Cystic Fibrosis Conference; Melbourne, Australia,
95. Schmitt L, Wiebel M, Frese F, et al. Exercise reduces airway sodium ion reabsorption in cystic fibrosis but not in
exercise asthma. Eur Respir J 2011;37:342–8.
96. Hebestreit A, Kersting U, Basler B, et al. Exercise inhibits
epithelial sodium channels in patients with cystic fibrosis.
Am J Respir Crit Care Med 2001;164:443–6.
97. Hebestreit A, Kieser S, Junge S, et al. Long-term effects
of a partially supervised conditioning programme in cystic
fibrosis. Eur Respir J 2010;35:578–83.
98. Dwyer T, McKeough ZJ. Differences in quality of life, lung
function and hospitalization rates for adults with cystic
fibrosis, according to exercise participation. J Cyst Fibros
2010; 9(S1): S69.
99. Tejero Garcia S, Giráldez Sánchez MA, Cejudo P, et al.
Bone health, daily physical activity, and exercise tolerance
in patients with cystic fibrosis. Chest 2011;140:475–81.
100. Dwyer TJ, Alison JA, McKeough ZJ, et al. Evaluation of
the SenseWear activity monitor during exercise in cystic
fibrosis and in health. Respir Med 2009;103:1511–7.
101. Moran A, Brunzell C, Cohen RC, et al. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical
practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care
102. Ryan G, Jahnke N, Remmington T. Inhaled antibiotics for
pulmonary exacerbations in cystic fibrosis. Cochrane Database Syst Rev 2012;12:CD008319.
103. Moskowitz SM, Silva SJ, Mayer-Hamblett N, et al. Shifting
patterns of inhaled antibiotic use in cystic fibrosis. Pediatr
104. Stenbit AE, Bullington WM, Heh JL, Flume PA. Timing
of inhaled tobramycin affects assessment of intravenous
tobramycin pharmacokinetic monitoring. J Cyst Fibros
105. Bosworth DG, Nielson DW. Effectiveness of home versus
hospital care in the routine treatment of cystic fibrosis. Pediatr Pulmonol 1997;24:42–7.
106. Nazer D, Abdulhamid I, Thomas R, Pendleton S. Home
versus hospital intravenous antibiotic therapy for acute
pulmonary exacerbations in children with cystic fibrosis.
Pediatr Pulmonol 2006;41:744–9.
107. Termoz A, Touzet S, Bourdy S, et al. Effectiveness of
home treatment for patients with cystic fibrosis: the intravenous administration of antibiotics to treat respiratory
infections. Pediatr Pulmonol 2008;43:908–15.
108. Thornton J, Elliott R, Tully MP, et al. Long term clinical
outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis. Thorax 2004;59:242–6.
109. Esmond G, Butler M, McCormack AM. Comparison of
hospital and home intravenous antibiotic therapy in adults
with cystic fibrosis. J Clin Nurs 2006;15:52–60.
110. Collaco JM, Green DM, Cutting GR, et al. Location and
duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes. Am J Respir Crit Care Med
111. Miall LS, McGinley NT, Brownlee KG, Conway SP. Methicillin resistant Staphylococcus aureus (MRSA) infection in
cystic fibrosis. Arch Dis Child 2001;84:160– 2.
112. Ren CL, Morgan WJ, Konstan MW, et al. Presence of
methicillin resistant Staphylococcus aureus in respiratory
cultures from cystic fibrosis patients is associated with
lower lung function. Pediatr Pulmonol 2007;42:513–8.
113. Szaff M, Hoiby N. Antibiotic treatment of Staphylococcus
aureus infection in cystic fibrosis. Acta Paediatr Scand
114. Trust CF. Antibiotic treatment for cystic fibrosis. Report
of the UK Cystic Fibrosis Trust Antibiotic Working Group
2009. 3rd ed. London.
115. Richard DA, Nousia-Arvanitakis S, Solich V, et al. Oral